Natco Pharma Ltd

Natco Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Natco Pharma Ltd

₹ 1,463 -1.97%
11 Dec 3:59 p.m.
natcopharma.co.in BSE: 524816 NSE: NATCOPHARM
About

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. [1]
NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.[2]

Key Points

Exports of formulations - Complex Generics [1]
The company is focused on niche opportunities in the US.
Focus on Para IV and First-to-File molecules
Started winning tenders in Asian markets including Malaysia and Thailand

Company is focused on high-barrier-to-entry products that are typically characterized by one or more of the following: Intricate Chemistry, Challenging delivery systems, Difficult or complex manufacturing process

Website BSE NSE
  • Market Cap ₹ 26,196 Cr.
  • Current Price ₹ 1,463
  • High / Low ₹ 1,639 / 755
  • Stock P/E 13.5
  • Book Value ₹ 399
  • Dividend Yield 0.65 %
  • ROCE 30.1 %
  • ROE 25.9 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 24.9%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE 500 BSE SmallCap BSE 400 MidSmallCap Index Nifty MidSmallcap 400 Nifty Smallcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
377 560 597 885 432 492 898 1,140 1,031 759 1,068 1,363 1,371
307 459 615 489 337 387 559 612 573 490 571 558 567
Operating Profit 70 102 -19 395 95 106 339 528 458 268 497 805 804
OPM % 19% 18% -3% 45% 22% 22% 38% 46% 44% 35% 47% 59% 59%
38 30 14 34 20 21 29 20 29 37 42 48 64
Interest 4 5 7 4 4 4 3 4 4 5 6 5 4
Depreciation 35 36 38 40 42 42 41 44 44 44 56 44 46
Profit before tax 70 91 -50 386 70 81 324 500 440 256 478 804 818
Tax % 7% 12% 2% 17% 19% 23% 15% 16% 16% 17% 19% 17% 17%
65 80 -50 320 57 62 276 420 369 213 386 668 676
EPS in Rs 3.57 4.41 -2.77 17.55 3.11 3.41 15.11 23.47 20.60 11.88 21.57 37.32 37.81
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
661 739 825 1,042 2,020 2,185 2,094 1,915 2,052 1,945 2,707 3,999 4,561
511 560 615 777 1,337 1,256 1,300 1,332 1,446 1,681 1,772 2,245 2,186
Operating Profit 150 179 210 266 683 928 795 583 606 264 936 1,754 2,374
OPM % 23% 24% 25% 25% 34% 42% 38% 30% 30% 14% 35% 44% 52%
1 17 0 12 14 40 130 107 104 99 105 126 191
Interest 26 37 32 23 18 15 19 22 13 18 14 19 20
Depreciation 22 30 47 51 54 66 81 100 117 143 164 187 190
Profit before tax 102 129 132 204 624 887 825 569 580 202 862 1,674 2,356
Tax % 36% 24% 1% 24% 22% 22% 22% 19% 24% 16% 17% 17%
66 98 130 156 485 695 642 458 442 170 715 1,388 1,944
EPS in Rs 4.58 6.21 8.10 9.02 27.88 37.74 35.24 25.31 24.18 9.31 39.18 77.51 108.58
Dividend Payout % 17% 16% 12% 14% 24% 22% 18% 27% 22% 48% 14% 12%
Compounded Sales Growth
10 Years: 18%
5 Years: 14%
3 Years: 25%
TTM: 28%
Compounded Profit Growth
10 Years: 30%
5 Years: 17%
3 Years: 49%
TTM: 72%
Stock Price CAGR
10 Years: 18%
5 Years: 20%
3 Years: 18%
1 Year: 93%
Return on Equity
10 Years: 17%
5 Years: 14%
3 Years: 16%
Last Year: 26%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 31 33 33 35 35 37 36 36 36 36 36 36 36
Reserves 502 693 813 1,261 1,614 3,035 3,452 3,737 4,085 4,227 4,837 5,817 7,114
338 240 312 113 222 173 386 316 268 416 167 371 208
209 229 226 413 446 470 428 498 403 430 617 682 886
Total Liabilities 1,080 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,657 6,906 8,245
583 645 710 710 833 1,019 1,227 1,584 2,023 2,312 2,427 2,491 2,541
CWIP 106 124 129 212 336 480 638 518 223 130 64 137 234
Investments 2 2 2 22 32 76 169 112 304 308 392 539 643
389 425 543 878 1,116 2,140 2,270 2,373 2,242 2,360 2,774 3,739 4,826
Total Assets 1,080 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,657 6,906 8,245

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
61 144 93 112 346 464 669 417 299 46 849 1,212
-111 -108 -120 -176 -299 -1,116 -611 -175 -107 4 -465 -1,026
26 -35 29 154 -48 651 -51 -251 -186 35 -363 -247
Net Cash Flow -24 0 2 90 -1 -2 7 -8 6 85 21 -62

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 72 59 85 92 86 106 88 105 73 116 115 109
Inventory Days 220 283 331 482 213 389 545 534 570 496 432 357
Days Payable 159 172 189 372 160 239 224 244 104 105 153 120
Cash Conversion Cycle 132 170 228 202 138 257 410 395 539 507 394 345
Working Capital Days 67 71 99 131 111 244 275 355 294 333 220 184
ROCE % 17% 18% 17% 18% 39% 35% 23% 14% 13% 4% 18% 30%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
48.86% 48.81% 48.80% 48.80% 48.82% 48.84% 49.76% 49.71% 49.71% 49.71% 49.71% 49.62%
12.26% 11.94% 11.65% 11.67% 11.73% 11.91% 11.03% 12.82% 13.72% 16.14% 17.45% 17.51%
18.08% 16.15% 15.30% 14.30% 14.93% 15.38% 15.15% 14.01% 11.26% 9.69% 7.86% 6.75%
20.80% 23.10% 24.25% 25.23% 24.53% 23.87% 24.08% 23.48% 25.32% 24.46% 24.99% 26.13%
No. of Shareholders 88,42185,82892,4491,21,3361,35,3971,53,6631,55,1811,63,7532,07,5712,28,4672,51,4853,02,944

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls